...
首页> 外文期刊>Case Reports in Oncology >Are 5-7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed Observations from a Case Series
【24h】

Are 5-7 Days of Folic Acid Supplementation Necessary prior to Pemetrexed Observations from a Case Series

机译:是从一个案例系列中进行培美曲塞观察之前需要补充5-7天的叶酸吗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: Current regulatory guidelines advise 5-7 days of folic acid supplementation prior to pemetrexed. Although taking folic acid during and after pemetrexed therapy is important, it remains unclear whether premedication is truly necessary, particularly as it can be inconvenient for patients, can contribute to their anxiety by delaying chemotherapy, and can create challenges in scheduling chemotherapy. Methods and Results: We retrospectively sought to identify and evaluate outcomes among non-small cell lung cancer patients who received less than the advised folic acid premedication. Only 8 patients were identified. However, upon critical examination of first-cycle chemotherapy outcomes, we observed no major adverse events with a shortened course of folic acid premedication. Conclusion: In the very rare circumstance where urgent therapy is warranted, a healthcare provider can lookto this small case series and find modest precedent for the safe administration of pemetrexed in the absence of a full week of folic acid premedication.
机译:目的:目前的法规指南建议在培美曲塞之前补充5-7天的叶酸。尽管在培美曲塞治疗期间和之后服用叶酸很重要,但仍不清楚是否确实需要进行处方药治疗,特别是因为它可能给患者带来不便,可能通过延迟化疗而加剧其焦虑感,并可能给化疗方案带来挑战。方法和结果:我们回顾性地寻求鉴定和评估非小细胞肺癌患者接受少于建议叶酸处方药治疗的预后。仅鉴定出8例患者。但是,在对第一周期化疗结果进行严格检查后,我们没有观察到叶酸预用药过程缩短的重大不良事件。结论:在极少数需要紧急治疗的情况下,医疗保健提供者可以查看这一小病例系列,并找到在没有整整一周叶酸药物治疗的情况下安全施用培美曲塞的适度先例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号